Related Experiment Video
Updated: Aug 28, 2025

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn's
James Irwin1,2,3, Anton Lord4, Emma Ferguson5
1QIMR Berghofer Medical Research Institute, Brisbane, Australia. jamesi@mdhb.health.nz.
Longitudinal laboratory testing can predict severe intestinal complications in Crohn's disease patients. A score based on albumin, mean cell volume, platelets, and C-reactive protein identifies at-risk individuals for earlier intervention.
Area of Science:
- Gastroenterology
- Clinical Medicine
- Predictive Analytics
Background:
- Crohn's disease can lead to severe intestinal complications like stenosis, fistulization, and perforation.
- Early prediction of these complications is crucial for timely treatment adjustments.
Purpose of the Study:
- To investigate the correlation between longitudinal laboratory test results and the occurrence of subsequent intestinal complications in Crohn's disease patients.
- To develop a predictive tool for identifying patients at higher risk of developing intestinal complications.
Main Methods:
- An observational cohort study analyzed data from Crohn's disease patients between 1994 and 2016.
- Cox regression was employed to identify laboratory variables associated with intestinal complications (fistula, stenosis, perforation).
- A clinical scoring tool was designed based on key laboratory parameters.
Main Results:
- In 246 patients, 134 complications were observed over a median of 5.72 years.
- The minimum or maximum laboratory values within a one-year window were most predictive of subsequent complications.
- A Longitudinal Laboratory score (≥2) demonstrated 62% sensitivity and 91% specificity in predicting complications.
Conclusions:
- Consistent changes in serum albumin, mean cell volume, platelet count, and C-reactive protein levels are associated with increased risk of complications.
- Longitudinal laboratory testing offers a rational basis for escalating therapy in Crohn's disease management.
- The developed scoring tool can aid in the early identification of patients requiring intensified treatment.
More Related Videos
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...